BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23696862)

  • 21. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway.
    Kim YH; Lee DH; Jeong JH; Guo ZS; Lee YJ
    Biochem Pharmacol; 2008 May; 75(10):1946-58. PubMed ID: 18377872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5.
    Fassl A; Tagscherer KE; Richter J; De-Castro Arce J; Savini C; Rösl F; Roth W
    Cell Death Dis; 2015 Oct; 6(10):e1921. PubMed ID: 26469969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
    James MA; Seibel WL; Kupert E; Hu XX; Potharla VY; Anderson MW
    Anticancer Drugs; 2015 Jun; 26(5):518-30. PubMed ID: 25646742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors.
    Kim B; Seo JH; Lee KY; Park B
    Int J Oncol; 2020 Mar; 56(3):821-834. PubMed ID: 32124960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
    Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
    Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.
    Jang JY; Jeon YK; Choi Y; Kim CW
    Mol Cancer; 2010 Sep; 9():262. PubMed ID: 20875141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells.
    Cheng X; Holenya P; Can S; Alborzinia H; Rubbiani R; Ott I; Wölfl S
    Mol Cancer; 2014 Sep; 13():221. PubMed ID: 25253202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
    Chen L; Meng Y; Guo X; Sheng X; Tai G; Zhang F; Cheng H; Zhou Y
    Apoptosis; 2016 Nov; 21(11):1291-1301. PubMed ID: 27629794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
    Zhuang H; Jiang W; Zhang X; Qiu F; Gan Z; Cheng W; Zhang J; Guan S; Tang B; Huang Q; Wu X; Huang X; Jiang W; Hu Q; Lu M; Hua ZC
    J Mol Med (Berl); 2013 Feb; 91(2):219-35. PubMed ID: 22948392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins.
    Park S; Cho DH; Andera L; Suh N; Kim I
    Mol Cell Biochem; 2013 Nov; 383(1-2):39-48. PubMed ID: 23846485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.
    Ivanov VN; Zhou H; Partridge MA; Hei TK
    Cancer Res; 2009 Apr; 69(8):3510-9. PubMed ID: 19351839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
    Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
    Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
    Guo X; Meng Y; Sheng X; Guan Y; Zhang F; Han Z; Kang Y; Tai G; Zhou Y; Cheng H
    Anticancer Drugs; 2017 Jan; 28(1):66-74. PubMed ID: 27603596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway.
    Cho HD; Gu IA; Won YS; Moon KD; Park KH; Seo KI
    Food Chem Toxicol; 2019 Apr; 126():223-232. PubMed ID: 30817944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
    Bui HTT; Le NH; Le QA; Kim SE; Lee S; Kang D
    Int J Med Sci; 2019; 16(11):1412-1423. PubMed ID: 31673231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1-dependent pathway.
    Deng Z; Yan H; Hu J; Zhang S; Peng P; Liu Q; Guo D
    PLoS One; 2012; 7(5):e37700. PubMed ID: 22662193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
    Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
    Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
    Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
    Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.